Found: 120
Select item for more details and to access through your institution.
Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early‐stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective study.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2022, v. 129, p. 23, doi. 10.1111/1471-0528.17325
- By:
- Publication type:
- Article
Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.
- Published in:
- Advanced Science, 2024, v. 11, n. 15, p. 1, doi. 10.1002/advs.202306229
- By:
- Publication type:
- Article
Embolization of uterine arteriovenous malformation.
- Published in:
- Iranian Journal of Reproductive Medicine, 2013, v. 11, n. 2, p. 159
- By:
- Publication type:
- Article
Comparison of laparoscopy and laparotomy for endometrial cancer
- Published in:
- International Journal of Gynecology & Obstetrics, 2012, v. 116, n. 3, p. 185, doi. 10.1016/j.ijgo.2011.10.022
- By:
- Publication type:
- Article
Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk.
- Published in:
- Molecular Biology Reports, 2013, v. 40, n. 10, p. 6001, doi. 10.1007/s11033-013-2709-x
- By:
- Publication type:
- Article
Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. e2217, doi. 10.1002/onco.13956
- By:
- Publication type:
- Article
Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0719-9
- By:
- Publication type:
- Article
Prognostic value of HE4 in patients with ovarian cancer.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 7, p. 1026, doi. 10.1515/cclm-2017-1176
- By:
- Publication type:
- Article
Tubal Origin of "Ovarian" Low-Grade Serous Carcinoma: A Gene Expression Profile Study.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/8659754
- By:
- Publication type:
- Article
Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 89, doi. 10.1186/1756-9966-31-89
- By:
- Publication type:
- Article
Enforced effect of tk-MCP-1 fusion gene in ovarian cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 74, doi. 10.1186/1756-9966-31-74
- By:
- Publication type:
- Article
Lymphatic targeting of hematoporphyrin monomethyl ether using poly (butyl-cyanoacrylate) based nanoparticle drug delivery system.
- Published in:
- Journal of the Iranian Chemical Society, 2018, v. 15, n. 8, p. 1733, doi. 10.1007/s13738-018-1370-7
- By:
- Publication type:
- Article
Rad50 promotes ovarian cancer progression through NF‐κB activation.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 23, p. 10961, doi. 10.1111/jcmm.17017
- By:
- Publication type:
- Article
Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 20, p. 3165, doi. 10.1002/cncr.28900
- By:
- Publication type:
- Article
HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01172-7
- By:
- Publication type:
- Article
Olaparib maintenance monotherapy in Chinese patients with platinum‐sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2022, v. 18, n. 6, p. 714, doi. 10.1111/ajco.13753
- By:
- Publication type:
- Article
The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-01120-3
- By:
- Publication type:
- Article
Ectopic Mammary Tissue as a Vulvar Mass in a Lactating Woman.
- Published in:
- Breast Journal, 2014, v. 20, n. 1, p. 91, doi. 10.1111/tbj.12212
- By:
- Publication type:
- Article
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34042-w
- By:
- Publication type:
- Article
Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 11, p. 1, doi. 10.1038/s41419-023-06301-1
- By:
- Publication type:
- Article
MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05000-7
- By:
- Publication type:
- Article
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 3, p. 1, doi. 10.1038/s41419-022-04670-7
- By:
- Publication type:
- Article
SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04630-1
- By:
- Publication type:
- Article
TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 12, p. 1, doi. 10.1038/s41419-021-04429-6
- By:
- Publication type:
- Article
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 4, p. 1, doi. 10.1038/s41419-021-03581-3
- By:
- Publication type:
- Article
MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 3, p. 1, doi. 10.1038/s41419-020-2356-9
- By:
- Publication type:
- Article
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1415-6
- By:
- Publication type:
- Article
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Indoleamine 2,3-dioxygenase levels at the normal and recurrent spontaneous abortion fetal-maternal interface.
- Published in:
- Journal of International Medical Research, 2013, v. 41, n. 4, p. 1135, doi. 10.1177/0300060513487642
- By:
- Publication type:
- Article
Hyperemesis gravidarum induced refeeding syndrome causes blood cell destruction: a case report and literature review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect.
- Published in:
- Journal of Biomaterials Applications, 2017, v. 32, n. 1, p. 66, doi. 10.1177/0885328217708458
- By:
- Publication type:
- Article
Macrophage ERα promoted invasion of endometrial cancer cell by mTOR/KIF5B‐mediated epithelial to mesenchymal transition.
- Published in:
- Immunology & Cell Biology, 2019, v. 97, n. 6, p. 563, doi. 10.1111/imcb.12245
- By:
- Publication type:
- Article
Effect of Indoleamine 2,3-Dioxygenase Expressed in HTR-8/ SVneo Cells on Decidual NK Cell Cytotoxicity.
- Published in:
- American Journal of Reproductive Immunology, 2016, v. 75, n. 5, p. 519, doi. 10.1111/aji.12481
- By:
- Publication type:
- Article
Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer.
- Published in:
- International Journal of Biological Sciences, 2022, v. 18, n. 3, p. 1188, doi. 10.7150/ijbs.65589
- By:
- Publication type:
- Article
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03409-9
- By:
- Publication type:
- Article
IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer.
- Published in:
- Oncology Letters, 2020, v. 20, n. 2, p. 1179, doi. 10.3892/ol.2020.11664
- By:
- Publication type:
- Article
53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 9917, doi. 10.3892/ol.2018.8596
- By:
- Publication type:
- Article
miR‑494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.
- Published in:
- Oncology Letters, 2018, v. 15, n. 3, p. 3075, doi. 10.3892/ol.2017.7651
- By:
- Publication type:
- Article
Effective treatment of a patient with stage IV ovarian cancer: A case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
An unexpected invasive hydatidiform mole in a rudimentary uterine horn: A case report.
- Published in:
- Oncology Letters, 2017, v. 14, n. 3, p. 2808, doi. 10.3892/ol.2017.6493
- By:
- Publication type:
- Article
Distinguishing between intramural pregnancy and choriocarcinoma: A case report.
- Published in:
- Oncology Letters, 2017, v. 13, n. 4, p. 2129, doi. 10.3892/ol.2017.5737
- By:
- Publication type:
- Article
Coexistence of benign struma ovarii, pseudo-Meigs' syndrome and elevated serum CA 125: Case report and review of the literature.
- Published in:
- Oncology Letters, 2015, v. 9, n. 4, p. 1739, doi. 10.3892/ol.2015.2927
- By:
- Publication type:
- Article
A retrospective clinicopathological analysis of small-cell carcinoma of the uterine cervix.
- Published in:
- Molecular & Clinical Oncology, 2014, v. 2, n. 1, p. 71, doi. 10.3892/mco.2013.193
- By:
- Publication type:
- Article
Light scattering pattern specific convolutional network static cytometry for label‐free classification of cervical cells.
- Published in:
- Cytometry. Part A, 2021, v. 99, n. 6, p. 610, doi. 10.1002/cyto.a.24349
- By:
- Publication type:
- Article
Two‐Dimensional Light Scattering Anisotropy Cytometry for Label‐Free Classification of Ovarian Cancer Cells via Machine Learning.
- Published in:
- Cytometry. Part A, 2020, v. 97, n. 1, p. 24, doi. 10.1002/cyto.a.23865
- By:
- Publication type:
- Article
2D light scattering static cytometry for label-free single cell analysis with submicron resolution.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 11, p. 1029, doi. 10.1002/cyto.a.22713
- By:
- Publication type:
- Article
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-0844-0
- By:
- Publication type:
- Article
Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article